4.6 Letter

Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands

Maartje Blom et al.

Summary: The majority of parents expressed support for NBS for SCID from both a public health and personal perspective, with emphasis on the emotional impact of an abnormal screening result. The study highlights the importance of uniform follow-up protocols and adequate information provision to address (long-term) stress and anxiety experienced by parents during and after referral. Moving towards universal SCID screening for all infants requires a close partnership of stakeholders, immunologists, geneticists, and pediatricians-immunologists in different countries.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

A Severe Neonatal Lymphopenia Associated With Administration of Azathioprine to the Mother in a Context of Crohn's Disease

Caroline Thomas et al.

JOURNAL OF CROHNS & COLITIS (2018)

Article Cell Biology

Epigenetic immune cell counting in human blood samples for immunodiagnostics

Udo Baron et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Letter Allergy

Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screening

Caroline Y. Kuo et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)

Article Gastroenterology & Hepatology

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

C. J. van der Woude et al.

JOURNAL OF CROHNS & COLITIS (2015)

Review Gastroenterology & Hepatology

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease

RB Gearry et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)